Cemtrex (NASDAQ:CETX) reported $8.80 million in sales this quarter. This is a 27.99 percent decrease over sales of $12.22 million the same period last year.
Why Are Talis Shares Trading Higher Today?
The FDA has granted Emergency Use Authorization (EUA) to Talis Biomedical Corporation’s (NASDAQ:TLIS) Talis One COVID-19 Test System, a nucleic acid amplification…